ConductScience.org, home

Library / Genes

SUCLG1: succinate-CoA ligase GDP/ADP-forming subunit alpha

1 protein, 31 patents, 0 drugs, 0 trials, 3,947 NIH grants and 5,579 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSUCLG1HGNC
Namesuccinate-CoA ligase GDP/ADP-forming subunit alphaHGNC
NCBI Gene ID8802NCBI Gene
HGNC IDHGNC:11449HGNC
EnsemblENSG00000163541NCBI Gene
AliasesGALPHA, MTDPS9, SUCLA1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P53597Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial3468Ensembl, GeneID, HGNCUniProt

Patents 31

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21172P53597Espacenet
JP 2026004568 A2026-01-1465717P53597Espacenet
EP 4641201 A22025-10-2911520P53597Espacenet
JP 2025147176 A2025-10-0612941P53597Espacenet
JP 2025529142 A2025-09-047832P53597Espacenet
US 12371689 B22025-07-297832P53597Espacenet
JP 2025517969 A2025-06-1211520P53597Espacenet
JP 2025028160 A2025-02-2812941P53597Espacenet
KR 1020250010750 A2025-01-2112941P53597Espacenet
JP 2024109657 A2024-08-1412948P53597Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3947

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
R01DA036596Regulation of Neuronal GPCR Signaling172,025NIH's project files
R01HL016037Molecular Regulation of Cardiovascular 7 TM Receptors132,025NIH's project files
ZIADA000493Functional and Pharmacological Significance of Receptor Heteromers in the CNS132,025NIH's project files
ZIAAI000738Control of G-protein Signaling: Role of RGSs122,025NIH's project files
P30CA016672Cancer Center Support Grant112,025NIH's project files
R01MH054137Structure and Function of Dopamine Receptors112,025NIH's project files
P30CA016086Cancer Center Support Grant102,025NIH's project files
P30CA086862Cancer Center Support Grant92,025NIH's project files
P30DK020572Michigan Diabetes Research Center (MDRC)92,025NIH's project files
R01MH084894Function of GPCR heteromeric complexes in brain92,025NIH's project files

Papers 5579

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42809568PubTator, text miningPubMed
42790561PubTator, text miningPubMed
42718820PubTator, text miningPubMed
42702836PubTator, text miningPubMed
42620795PubTator, text miningPubMed
42606521PubTator, text miningPubMed
42547588PubTator, text miningPubMed
42538989PubTator, text miningPubMed
42523653PubTator, text miningPubMed
42485388PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license